Skip to main
AHR
AHR logo

AHR Stock Forecast & Price Target

AHR Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 25%
Buy 67%
Hold 8%
Sell 0%
Strong Sell 0%

Bulls say

American Healthcare REIT Inc exhibits a robust financial outlook, evidenced by a 4.1% year-over-year rental rate growth, alongside remarkable same-store net operating income (NOI) growth, which stands at 25.3% for its senior housing operating portfolio and 21.7% for its integrated senior health campuses. The company has positioned itself favorably within the healthcare REIT sector, achieving the highest funds from operations (FFO) growth rate, supported by strong industry tailwinds and internal operational efficiencies. Furthermore, with an improved cost of capital enabling strategic investments, AHR is anticipated to maintain significant organic growth, projecting a two-year compound annual growth rate (CAGR) of 11.8% for Trilogy and 15.5% for its senior housing operations.

Bears say

American Healthcare REIT Inc. exhibits a leverage ratio of 31.1% on a net debt to Gross Asset Value (GAV) basis as of 2Q25, a decline from 42.2% a year prior, indicating improved financial stability but persistent concerns regarding tenant performance due to potential economic and regulatory challenges. The net debt to annualized EBITDA ratio has also improved to 3.5x, but ongoing risks related to acquisition and operational performance in certain geographies may hinder the company's ability to meet earnings expectations, creating additional headwinds for future profitability. Overall, these financial metrics, combined with external risk factors, contribute to a negative outlook for the company's stock.

AHR has been analyzed by 12 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 67% recommend Buy, 8% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of American Healthcare REIT Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About American Healthcare REIT Inc (AHR) Forecast

Analysts have given AHR a Buy based on their latest research and market trends.

According to 12 analysts, AHR has a Buy consensus rating as of Dec 13, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $50.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $50.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

American Healthcare REIT Inc (AHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.